Impact of Molecular Genetics on Outcome in Myelofibrosis Patients after Allogeneic Stem Cell Transplantation

Highlights • Molecular mutations have impact on outcome after allogeneic stem cell transplantation in myelofibrosis • CALR mutated patients have a significant improved overall survival • ASXL-1 and IDH2 mutated patients have a lower PFS

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Biology of blood and marrow transplantation 2017-07, Vol.23 (7), p.1095-1101
Hauptverfasser:	Kröger, Nicolaus, Panagiota, Victoria, Badbaran, Anita, Zabelina, Tatjana, Triviai, Ioanna, Araujo Cruz, Michelle Maria, Shahswar, Rabia, Ayuk, Francis, Gehlhaar, Marten, Wolschke, Christine, Bollin, Robin, Walter, Carolin, Dugas, Martin, Wiehlmann, Lutz, Lehmann, Ulrich, Koenecke, Christian, Chaturvedi, Anuhar, Alchalby, Haefaa, Stadler, Michael, Eder, Matthias, Christopeit, Max, Göhring, Gudrun, Koenigsmann, Michael, Schlegelberger, Brigitte, Kreipe, Hans-Heinrich, Ganser, Arnold, Stocking, Carol, Fehse, Boris, Thol, Felicitas, Heuser, Michael
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Allogeneic stem cell transplantation ASXL1 Calreticulin Female Hematology, Oncology and Palliative Medicine Hematopoietic Stem Cell Transplantation - methods Humans Male Middle Aged Molecular Biology - methods Molecular genetics Myelofibrosis Primary Myelofibrosis - genetics Transplantation Conditioning - methods Transplantation, Homologous - methods Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Highlights • Molecular mutations have impact on outcome after allogeneic stem cell transplantation in myelofibrosis • CALR mutated patients have a significant improved overall survival • ASXL-1 and IDH2 mutated patients have a lower PFS
ISSN:	1083-8791 1523-6536
DOI:	10.1016/j.bbmt.2017.03.034